
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.17 | 0.17 | 0.00 |
Shares | 98.99 | 98.99 | 0.00 |
Convertible | 0.04 | 0.04 | 0.00 |
Preferred | 0.25 | 0.25 | 0.00 |
Other | 0.53 | 0.53 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.92 | 18.81 |
Price to Book | 4.14 | 4.29 |
Price to Sales | 1.61 | 2.29 |
Price to Cash Flow | 12.87 | 15.42 |
Dividend Yield | 1.37 | 1.19 |
5 Years Earnings Growth | 10.28 | 10.59 |
Number of long holdings: 105
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 8.65 | 625.65 | -2.37% | |
UnitedHealth | US91324P1021 | 4.48 | 250.89 | +2.54% | |
AstraZeneca | GB0009895292 | 4.42 | 11,076.0 | +1.41% | |
Boston Scientific | US1011371077 | 3.46 | 103.14 | +0.17% | |
Abbott Labs | US0028241000 | 3.40 | 134.28 | +1.68% | |
J&J | US4781601046 | 3.28 | 173.33 | +1.05% | |
Sanofi | FR0000120578 | 3.05 | 81.28 | +0.43% | |
Amgen | US0311621009 | 2.83 | 288.23 | +1.24% | |
Novartis ADR | US66987V1098 | 2.63 | 116.84 | +0.79% | |
argenx ADR | US04016X1019 | 2.60 | 661.83 | -1.56% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Janus Research D | 19.45B | 13.21 | 25.25 | 15.00 | ||
Janus Balanced I | 12.41B | 9.22 | 11.33 | 9.44 | ||
Janus Enterprise I | 9.92B | 4.65 | 11.07 | 12.02 | ||
Janus Henderson Balanced Portfolio | 8.85B | 9.16 | 11.13 | 9.17 | ||
Janus Enterprise N | 6.8B | 4.71 | 11.18 | 12.13 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review